Literature DB >> 18791226

A targeted deleterious allele of the splicing factor SCNM1 in the mouse.

Viive M Howell1, Georgius de Haan, Sarah Bergren, Julie M Jones, Cymbeline T Culiat, Edward J Michaud, Wayne N Frankel, Miriam H Meisler.   

Abstract

The auxiliary spliceosomal protein SCNM1 contributes to recognition of nonconsensus splice donor sites. SCNM1 was first identified as a modifier of the severity of a sodium channelopathy in the mouse. The most severely affected strain, C57BL/6J, carries the variant allele SCNM1R187X, which is defective in splicing the mutated donor site in the Scn8a(medJ) transcript. To further probe the in vivo function of SCNM1, we constructed a floxed allele and generated a mouse with constitutive deletion of exons 3-5. The SCNM1Delta3-5 protein is produced and correctly localized to the nucleus, but is more functionally impaired than the C57BL/6J allele. Deficiency of SCNM1 did not significantly alter other brain transcripts. We characterized an ENU-induced allele of Scnm1 and evaluated the ability of wild-type SCNM1 to rescue lethal mutations of I-mfa and Brunol4. The phenotypes of the Scnm1Delta3-5 mutant confirm the role of this splice factor in processing the Scn8a(medJ) transcript and provide a new allele of greater severity for future studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18791226      PMCID: PMC2581945          DOI: 10.1534/genetics.108.094227

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  32 in total

1.  Determinants of the inherent strength of human 5' splice sites.

Authors:  Xavier Roca; Ravi Sachidanandam; Adrian R Krainer
Journal:  RNA       Date:  2005-05       Impact factor: 4.942

Review 2.  The splicing machinery is a genetic modifier of disease severity.

Authors:  Malka Nissim-Rafinia; Batsheva Kerem
Journal:  Trends Genet       Date:  2005-09       Impact factor: 11.639

3.  Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia.

Authors:  Matthew M Hims; El Chérif Ibrahim; Maire Leyne; James Mull; Lijuan Liu; Conxi Lazaro; Ranjit S Shetty; Sandra Gill; James F Gusella; Robin Reed; Susan A Slaugenhaupt
Journal:  J Mol Med (Berl)       Date:  2007-01-06       Impact factor: 4.599

4.  Common molecular pathways mediate long-term potentiation of synaptic excitation and slow synaptic inhibition.

Authors:  Cindy Shen Huang; Song-Hai Shi; Jernej Ule; Matteo Ruggiu; Laura A Barker; Robert B Darnell; Yuh Nung Jan; Lily Yeh Jan
Journal:  Cell       Date:  2005-10-07       Impact factor: 41.582

5.  Unconventional intronic splice site mutation in SCN5A associates with cardiac sodium channelopathy.

Authors:  T Rossenbacker; E Schollen; C Kuipéri; T J L de Ravel; K Devriendt; G Matthijs; D Collen; H Heidbüchel; P Carmeliet
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

6.  An RNA map predicting Nova-dependent splicing regulation.

Authors:  Jernej Ule; Giovanni Stefani; Aldo Mele; Matteo Ruggiu; Xuning Wang; Bahar Taneri; Terry Gaasterland; Benjamin J Blencowe; Robert B Darnell
Journal:  Nature       Date:  2006-10-25       Impact factor: 49.962

7.  Detection and measurement of alternative splicing using splicing-sensitive microarrays.

Authors:  Karpagam Srinivasan; Lily Shiue; Justin D Hayes; Ross Centers; Sean Fitzwater; Rebecca Loewen; Lillian R Edmondson; Jessica Bryant; Michael Smith; Claire Rommelfanger; Valerie Welch; Tyson A Clark; Charles W Sugnet; Kenneth J Howe; Yael Mandel-Gutfreund; Manuel Ares
Journal:  Methods       Date:  2005-12       Impact factor: 3.608

8.  Efficient gene-driven germ-line point mutagenesis of C57BL/6J mice.

Authors:  Edward J Michaud; Cymbeline T Culiat; Mitchell L Klebig; Paul E Barker; K T Cain; Debra J Carpenter; Lori L Easter; Carmen M Foster; Alysyn W Gardner; Z Y Guo; Kay J Houser; Lori A Hughes; Marilyn K Kerley; Zhaowei Liu; Robert E Olszewski; Irina Pinn; Ginger D Shaw; Sarah G Shinpock; Ann M Wymore; Eugene M Rinchik; Dabney K Johnson
Journal:  BMC Genomics       Date:  2005-11-21       Impact factor: 3.969

9.  Complex seizure disorder caused by Brunol4 deficiency in mice.

Authors:  Yan Yang; Connie L Mahaffey; Nathalie Bérubé; Terry P Maddatu; Gregory A Cox; Wayne N Frankel
Journal:  PLoS Genet       Date:  2007-07       Impact factor: 5.917

Review 10.  Comparative genetic analysis: the utility of mouse genetic systems for studying human monogenic disease.

Authors:  Peter L Oliver; Emmanuelle Bitoun; Kay E Davies
Journal:  Mamm Genome       Date:  2007-05-21       Impact factor: 2.957

View more
  7 in total

Review 1.  Genetic modifiers of neurological disease.

Authors:  Jennifer A Kearney
Journal:  Curr Opin Genet Dev       Date:  2011-01-19       Impact factor: 5.578

Review 2.  The neurogenetics of alternative splicing.

Authors:  Celine K Vuong; Douglas L Black; Sika Zheng
Journal:  Nat Rev Neurosci       Date:  2016-05       Impact factor: 34.870

Review 3.  Cerebellum-related characteristics of Scn8a-mutant mice.

Authors:  Kejian Chen; Donald A Godfrey; Omer Ilyas; Jiansong Xu; Todd W Preston
Journal:  Cerebellum       Date:  2009-05-08       Impact factor: 3.847

4.  The ataxia3 mutation in the N-terminal cytoplasmic domain of sodium channel Na(v)1.6 disrupts intracellular trafficking.

Authors:  Lisa M Sharkey; Xiaoyang Cheng; Valerie Drews; David A Buchner; Julie M Jones; Monica J Justice; Stephen G Waxman; Sulayman D Dib-Hajj; Miriam H Meisler
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

Review 5.  Sodium channelopathies in neurodevelopmental disorders.

Authors:  Miriam H Meisler; Sophie F Hill; Wenxi Yu
Journal:  Nat Rev Neurosci       Date:  2021-02-02       Impact factor: 34.870

Review 6.  Modifier genes and the plasticity of genetic networks in mice.

Authors:  Bruce A Hamilton; Benjamin D Yu
Journal:  PLoS Genet       Date:  2012-04-12       Impact factor: 5.917

7.  RBFOX1 cooperates with MBNL1 to control splicing in muscle, including events altered in myotonic dystrophy type 1.

Authors:  Roscoe Klinck; Angélique Fourrier; Philippe Thibault; Johanne Toutant; Mathieu Durand; Elvy Lapointe; Marie-Laure Caillet-Boudin; Nicolas Sergeant; Geneviève Gourdon; Giovanni Meola; Denis Furling; Jack Puymirat; Benoit Chabot
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.